{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:42:26Z","timestamp":1790862146326,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"International Post-Doc Research Fund given by Charles University in Prague"},{"name":"PRVOUK-P26\/LF1\/4 given by Charles University in Prague"},{"name":"AZV, Ministry of Health, Czech Republic","award":["15-28967A"],"award-info":[{"award-number":["15-28967A"]}]},{"name":"AZV, Ministry of Health, Czech Republic","award":["15-28616A"],"award-info":[{"award-number":["15-28616A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12035-016-0121-y","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T02:23:58Z","timestamp":1474597438000},"page":"5894-5904","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["In Vitro Effects of Cognitives and Nootropics on Mitochondrial Respiration and Monoamine Oxidase Activity"],"prefix":"10.1007","volume":"54","author":[{"given":"Namrata","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Hroudov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"Fi\u0161ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"issue":"8","key":"121_CR1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2174\/138945012802009026","volume":"13","author":"H Zheng","year":"2012","unstructured":"Zheng H, Fridkin M, Youdim MB (2012) Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer\u2019s therapy. Curr Drug Targets 13(8):1089\u20131106","journal-title":"Curr Drug Targets"},{"key":"121_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.ejmech.2016.03.084","volume":"121","author":"J Hroudov\u00e1","year":"2016","unstructured":"Hroudov\u00e1 J, Singh N, Fi\u0161ar Z, Ghosh KK (2016) Progress in drug development for Alzheimer\u2019s disease: an overview in relation to mitochondrial energy metabolism. Eur J Med Chem 121:774\u2013784. doi: 10.1016\/j.ejmech.2016.03.084","journal-title":"Eur J Med Chem"},{"issue":"6","key":"121_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1517\/14740338.2014.914168","volume":"13","author":"F Zemek","year":"2014","unstructured":"Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J, Kuca K (2014) Outcomes of Alzheimer\u2019s disease therapy with acetylcholinesterase inhibitors and memantine. Expert Opin Drug Saf 13(6):759\u2013774. doi: 10.1517\/14740338.2014.914168","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"121_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1684\/pnv.2010.0208","volume":"8","author":"A Nieoullon","year":"2010","unstructured":"Nieoullon A (2010) Acetylcholinesterase inhibitors in Alzheimer\u2019s disease: further comments on their mechanisms of action and therapeutic consequences. Psychol Neuropsychiatrie du vieillissement 8(2):123\u2013131. doi: 10.1684\/pnv.2010.0208","journal-title":"Psychol Neuropsychiatrie du vieillissement"},{"issue":"8","key":"121_CR5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1567205011310080011","volume":"10","author":"O Soukup","year":"2013","unstructured":"Soukup O, Jun D, Zdarova-Karasova J, Patocka J, Musilek K, Korabecny J, Krusek J, Kaniakova M, Sepsova V, Mandikova J, Trejtnar F, Pohanka M, Drtinova L, Pavlik M, Tobin G, Kuca K (2013) A resurrection of 7-MEOTA: a comparison with tacrine. Curr Alzheim Res 10(8):893\u2013906","journal-title":"Curr Alzheim Res"},{"issue":"12","key":"121_CR6","doi-asserted-by":"publisher","first-page":"8804","DOI":"10.3390\/molecules15128804","volume":"15","author":"J Korabecny","year":"2010","unstructured":"Korabecny J, Musilek K, Holas O, Nepovimova E, Jun D, Zemek F, Opletalova V, Patocka J, Dohnal V, Nachon F, Hroudova J, Fisar Z, Kuca K (2010) Synthesis and in vitro evaluation of N-(Bromobut-3-en-2-yl)-7-methoxy-1,2,3,4-tetrahydroacridin-9-amine as a cholinesterase inhibitor with regard to Alzheimer\u2019s disease treatment. Mol (Basel, Switzerland) 15(12):8804\u20138812. doi: 10.3390\/molecules15128804","journal-title":"Mol (Basel, Switzerland)"},{"issue":"20","key":"121_CR7","doi-asserted-by":"publisher","first-page":"6093","DOI":"10.1016\/j.bmcl.2010.08.044","volume":"20","author":"J Korabecny","year":"2010","unstructured":"Korabecny J, Musilek K, Holas O, Binder J, Zemek F, Marek J, Pohanka M, Opletalova V, Dohnal V, Kuca K (2010) Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease. Bioorg Med Chem Lett 20(20):6093\u20136095. doi: 10.1016\/j.bmcl.2010.08.044","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"121_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1124\/jpet.105.090365","volume":"315","author":"E Arias","year":"2005","unstructured":"Arias E, Gallego-Sandin S, Villarroya M, Garcia AG, Lopez MG (2005) Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J Pharmacol Exp Ther 315(3):1346\u20131353. doi: 10.1124\/jpet.105.090365","journal-title":"J Pharmacol Exp Ther"},{"key":"121_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2015.02.020","author":"CY Ye","year":"2015","unstructured":"Ye CY, Lei Y, Tang XC, Zhang HY (2015) Donepezil attenuates Abeta-associated mitochondrial dysfunction and reduces mitochondrial Abeta accumulation in vivo and in vitro. Neuropharmacology. doi: 10.1016\/j.neuropharm.2015.02.020","journal-title":"Neuropharmacology"},{"issue":"6 Suppl","key":"121_CR10","first-page":"S61","volume":"6","author":"SA Lipton","year":"2004","unstructured":"Lipton SA (2004) Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer\u2019s disease and other neurologic disorders. J Alzheimer\u2019s Dis : JAD 6(6 Suppl):S61\u2013S74","journal-title":"J Alzheimer\u2019s Dis : JAD"},{"issue":"1","key":"121_CR11","first-page":"80","volume":"11","author":"MN Sabbagh","year":"2010","unstructured":"Sabbagh MN, Shill HA (2010) Latrepirdine, a potential novel treatment for Alzheimer\u2019s disease and Huntington\u2019s chorea. Curr Opin Invest Drugs (London, England : 2000) 11(1):80\u201391","journal-title":"Curr Opin Invest Drugs (London, England : 2000)"},{"key":"121_CR12","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1038\/tp.2013.92","volume":"3","author":"P Weisova","year":"2013","unstructured":"Weisova P, Alvarez SP, Kilbride SM, Anilkumar U, Baumann B, Jordan J, Bernas T, Huber HJ, Dussmann H, Prehn JH (2013) Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability. Transl Psychiatry 3:e317. doi: 10.1038\/tp.2013.92","journal-title":"Transl Psychiatry"},{"issue":"2","key":"121_CR13","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1476-5381.2010.00656.x","volume":"160","author":"C Kurz","year":"2010","unstructured":"Kurz C, Ungerer I, Lipka U, Kirr S, Schutt T, Eckert A, Leuner K, Muller WE (2010) The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide. Br J Pharmacol 160(2):246\u2013257. doi: 10.1111\/j.1476-5381.2010.00656.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"121_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0706459","volume":"147","author":"U Keil","year":"2006","unstructured":"Keil U, Scherping I, Hauptmann S, Schuessel K, Eckert A, Muller WE (2006) Piracetam improves mitochondrial dysfunction following oxidative stress. Br J Pharmacol 147(2):199\u2013208. doi: 10.1038\/sj.bjp.0706459","journal-title":"Br J Pharmacol"},{"issue":"9","key":"121_CR15","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/aps.2012.128","volume":"33","author":"HY Zhang","year":"2012","unstructured":"Zhang HY (2012) New insights into huperzine A for the treatment of Alzheimer\u2019s disease. Acta Pharmacol Sin 33(9):1170\u20131175. doi: 10.1038\/aps.2012.128","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"121_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/cyto.a.20089","volume":"62","author":"G Mattiasson","year":"2004","unstructured":"Mattiasson G (2004) Analysis of mitochondrial generation and release of reactive oxygen species. Cytom Part A: J Int Soc Anal Cytol 62(2):89\u201396. doi: 10.1002\/cyto.a.20089","journal-title":"Cytom Part A: J Int Soc Anal Cytol"},{"issue":"Pt 5","key":"121_CR17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1042\/bst0360976","volume":"36","author":"J Hirst","year":"2008","unstructured":"Hirst J, King MS, Pryde KR (2008) The production of reactive oxygen species by complex I. Biochem Soc Trans 36(Pt 5):976\u2013980. doi: 10.1042\/bst0360976","journal-title":"Biochem Soc Trans"},{"issue":"31","key":"121_CR18","doi-asserted-by":"publisher","first-page":"21649","DOI":"10.1074\/jbc.M803236200","volume":"283","author":"S Drose","year":"2008","unstructured":"Drose S, Brandt U (2008) The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. J Biol Chem 283(31):21649\u201321654. doi: 10.1074\/jbc.M803236200","journal-title":"J Biol Chem"},{"issue":"12","key":"121_CR19","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1089\/ars.2011.4173","volume":"16","author":"K Leuner","year":"2012","unstructured":"Leuner K, Schutt T, Kurz C, Eckert SH, Schiller C, Occhipinti A, Mai S, Jendrach M, Eckert GP, Kruse SE, Palmiter RD, Brandt U, Drose S, Wittig I, Willem M, Haass C, Reichert AS, Muller WE (2012) Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid Redox Signal 16(12):1421\u20131433. doi: 10.1089\/ars.2011.4173","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"121_CR20","first-page":"645","volume":"31","author":"Z Fi\u0161ar","year":"2010","unstructured":"Fi\u0161ar Z, Hroudov\u00e1 J, Raboch J (2010) Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuro Endocrinol Lett 31(5):645\u2013656","journal-title":"Neuro Endocrinol Lett"},{"issue":"6","key":"121_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00210-010-0517-6","volume":"381","author":"Z Fisar","year":"2010","unstructured":"Fisar Z (2010) Inhibition of monoamine oxidase activity by cannabinoids. Naunyn Schmiedeberg\u2019s Arch Pharmacol 381(6):563\u2013572. doi: 10.1007\/s00210-010-0517-6","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"2","key":"121_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.toxlet.2010.12.023","volume":"201","author":"Z Fi\u0161ar","year":"2011","unstructured":"Fi\u0161ar Z, Hroudov\u00e1 J, Kor\u00e1be\u010dn\u00fd J, Mus\u00edlek K, Ku\u010da K (2011) In vitro effects of acetylcholinesterase reactivators on monoamine oxidase activity. Toxicol Lett 201(2):176\u2013180. doi: 10.1016\/j.toxlet.2010.12.023","journal-title":"Toxicol Lett"},{"issue":"10","key":"121_CR23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0006-3223(03)00414-1","volume":"54","author":"G Pinna","year":"2003","unstructured":"Pinna G, Broedel O, Eravci M, Stoltenburg-Didinger G, Plueckhan H, Fuxius S, Meinhold H, Baumgartner A (2003) Thyroid hormones in the rat amygdala as common targets for antidepressant drugs, mood stabilizers, and sleep deprivation. Biol Psychiatry 54(10):1049\u20131059","journal-title":"Biol Psychiatry"},{"issue":"1","key":"121_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265\u2013275","journal-title":"J Biol Chem"},{"issue":"3","key":"121_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neuint.2009.11.011","volume":"56","author":"J Folbergrov\u00e1","year":"2010","unstructured":"Folbergrov\u00e1 J, Jesina P, Haugvicov\u00e1 R, Lis\u00fd V, Houstek J (2010) Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid. Neurochem Int 56(3):394\u2013403. doi: 10.1016\/j.neuint.2009.11.011","journal-title":"Neurochem Int"},{"issue":"3","key":"121_CR26","first-page":"336","volume":"31","author":"J Hroudova","year":"2010","unstructured":"Hroudova J, Fisar Z (2010) Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers. Neuro Endocrinol Lett 31(3):336\u2013342","journal-title":"Neuro Endocrinol Lett"},{"key":"121_CR27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0076-6879(96)64044-0","volume":"264","author":"IA Trounce","year":"1996","unstructured":"Trounce IA, Kim YL, Jun AS, Wallace DC (1996) Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264:484\u2013509","journal-title":"Methods Enzymol"},{"issue":"1","key":"121_CR28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0009-8981(94)90055-8","volume":"228","author":"P Rustin","year":"1994","unstructured":"Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, Saudubray JM, Munnich A (1994) Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta; Int J Clin Chem 228(1):35\u201351","journal-title":"Clin Chim Acta; Int J Clin Chem"},{"key":"121_CR29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0076-6879(69)13005-0","volume":"13","author":"PA Srere","year":"1969","unstructured":"Srere PA (1969) Citrate synthase: [EC 4.1.3.7 citrate oxaloacetate-lyase (CoA acetylating)]. Methods Enzymol 13:3\u201311","journal-title":"Methods Enzymol"},{"issue":"3","key":"121_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.toxlet.2012.07.017","volume":"213","author":"J Hroudov\u00e1","year":"2012","unstructured":"Hroudov\u00e1 J, Fi\u0161ar Z (2012) In vitro inhibition of mitochondrial respiratory rate by antidepressants. Toxicol Lett 213(3):345\u2013352. doi: 10.1016\/j.toxlet.2012.07.017","journal-title":"Toxicol Lett"},{"key":"121_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-1-61779-382-0_3","volume":"810","author":"D Pesta","year":"2012","unstructured":"Pesta D, Gnaiger E (2012) High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol (Clifton, NJ) 810:25\u201358. doi: 10.1007\/978-1-61779-382-0_3","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"10","key":"121_CR32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0006-2952(76)90359-2","volume":"25","author":"B Ekstedt","year":"1976","unstructured":"Ekstedt B (1976) Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria. Biochem Pharmacol 25(10):1133\u20131138","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"121_CR33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1254\/jjp.81.115","volume":"81","author":"T Egashira","year":"1999","unstructured":"Egashira T, Takayama F, Yamanaka Y (1999) The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species. Jpn J Pharmacol 81(1):115\u2013121","journal-title":"Jpn J Pharmacol"},{"issue":"5","key":"121_CR34","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.0022-3042.2002.00744.x","volume":"80","author":"Y Liu","year":"2002","unstructured":"Liu Y, Fiskum G, Schubert D (2002) Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 80(5):780\u2013787","journal-title":"J Neurochem"},{"issue":"10","key":"121_CR35","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1016\/j.bbagen.2013.05.035","volume":"1830","author":"T Ross","year":"2013","unstructured":"Ross T, Szczepanek K, Bowler E, Hu Y, Larner A, Lesnefsky EJ, Chen Q (2013) Reverse electron flow-mediated ROS generation in ischemia-damaged mitochondria: role of complex I inhibition vs. depolarization of inner mitochondrial membrane. Biochim Biophys Acta 1830(10):4537\u20134542. doi: 10.1016\/j.bbagen.2013.05.035","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"121_CR36","first-page":"259","volume":"32","author":"J Hroudov\u00e1","year":"2011","unstructured":"Hroudov\u00e1 J, Fi\u0161ar Z, Kor\u00e1be\u010dn\u00fd J, Ku\u010da K (2011) In vitro effects of acetylcholinesterase inhibitors and reactivators on complex I of electron transport chain. Neuro Endocrinol Lett 32(3):259\u2013263","journal-title":"Neuro Endocrinol Lett"},{"issue":"4","key":"121_CR37","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.bcp.2007.10.019","volume":"75","author":"J McAllister","year":"2008","unstructured":"McAllister J, Ghosh S, Berry D, Park M, Sadeghi S, Wang KX, Parker WD, Swerdlow RH (2008) Effects of memantine on mitochondrial function. Biochem Pharmacol 75(4):956\u2013964. doi: 10.1016\/j.bcp.2007.10.019","journal-title":"Biochem Pharmacol"},{"key":"121_CR38","doi-asserted-by":"crossref","unstructured":"Casademont J, Miro O, Rodriguez-Santiago B, Viedma P, Blesa R, Cardellach F (2003) Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer\u2019s disease. In: J Neurol Sci, vol 206. vol 1. Netherlands, pp 23\u201326","DOI":"10.1016\/S0022-510X(02)00319-2"},{"issue":"5","key":"121_CR39","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1042\/bst20130054","volume":"41","author":"C Stockburger","year":"2013","unstructured":"Stockburger C, Kurz C, Koch KA, Eckert SH, Leuner K, Muller WE (2013) Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam. Biochem Soc Trans 41(5):1331\u20131334. doi: 10.1042\/bst20130054","journal-title":"Biochem Soc Trans"},{"key":"121_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9249-4","author":"A Ustyugov","year":"2015","unstructured":"Ustyugov A, Shevtsova E, Bachurin S (2015) Novel sites of neuroprotective action of Dimebon (latrepirdine). Mol Neurobiol. doi: 10.1007\/s12035-015-9249-4","journal-title":"Mol Neurobiol"},{"key":"121_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ejmech.2014.04.078","volume":"80","author":"L Wang","year":"2014","unstructured":"Wang L, Esteban G, Ojima M, Bautista-Aguilera OM, Inokuchi T, Moraleda I, Iriepa I, Samadi A, Youdim MB, Romero A, Soriano E, Herrero R, Fernandez Fernandez AP, Ricardo Martinez M, Marco-Contelles J, Unzeta M (2014) Donepezil + propargylamine +8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer\u2019s disease. Eur J Med Chem 80:543\u2013561. doi: 10.1016\/j.ejmech.2014.04.078","journal-title":"Eur J Med Chem"},{"key":"121_CR42","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ejmech.2013.01.039","volume":"62","author":"C Lu","year":"2013","unstructured":"Lu C, Zhou Q, Yan J, Du Z, Huang L, Li X (2013) A novel series of tacrine-selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 62:745\u2013753. doi: 10.1016\/j.ejmech.2013.01.039","journal-title":"Eur J Med Chem"},{"issue":"6","key":"121_CR43","first-page":"700","volume":"101","author":"SK Shadurskaia","year":"1986","unstructured":"Shadurskaia SK, Khomenko AI, Pereverzev VA, Balaklevskii AI (1986) Neuromediator mechanisms of the effect of the antihistamine agent dimebone on the brain. Biull Eksp Biol Med 101(6):700\u2013702","journal-title":"Biull Eksp Biol Med"},{"issue":"3","key":"121_CR44","first-page":"16","volume":"51","author":"SL Stancheva","year":"1988","unstructured":"Stancheva SL, Alova LG (1988) Effect of centrophenoxine, piracetam and aniracetam on the monoamine oxidase activity in different brain structures of rats. Farmakol Toksikol 51(3):16\u201318","journal-title":"Farmakol Toksikol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0121-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0121-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0121-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T01:41:54Z","timestamp":1657330914000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0121-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["121"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0121-y","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,23]]}}}